Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Earnings

1933 Industries Reports Second Quarter 2026 Financial Results

1933 Industries Posts Q2 Revenue Slide as Cost Cuts Mask Nevada Cannabis Headwinds

Executive Summary
  • 1933 Industries reported Q2 fiscal 2026 revenue of C$7.9M, a 6% year-over-year decline from C$8.4M.
  • Gross profit contracted to C$1.9M, compressing the gross margin to 24% from 34% in the prior year period.
  • Operating expenses were aggressively reduced to C$2.1M from C$3.7M YoY, driven by lower license taxes and insurance costs.
  • The company posted a net loss of C$0.2M, a notable improvement from the C$0.89M net loss in the comparable prior period.
  • Management highlighted the AMA brand maintaining top-5 positioning in Nevada, with flower ranking climbing to 1st and concentrates holding 2nd as of February 2026.
  • Revenue and margin declines were attributed to falling wholesale flower prices, competition from illicit hemp-derived cannabinoids, and reduced Las Vegas tourism.
  • The release points to anticipated federal regulatory changes in November 2026 that would redefine hemp and restrict psychoactive hemp-derived products, which management believes will benefit licensed Nevada operators.
Material Impact
  • The Q2 results are a mixed but largely expected outcome. Top-line contraction and margin compression reflect persistent macro headwinds in the Nevada cannabis market, while the narrowed net loss is entirely a function of cost-cutting rather than operational growth.
  • This release does not deviate from the trajectory established in Q1 FY2026, where the company achieved a small net profit through similar expense reductions. The reversion to a minor net loss in Q2 confirms that profitability remains fragile and highly dependent on overhead management rather than revenue expansion.
  • The regulatory catalyst cited (November 2026 hemp redefinition) is a forward-looking industry-wide tailwind, not a company-specific near-term catalyst. It does not alter the immediate liquidity or operational reality.
  • Given the stock's micro-cap valuation and extreme illiquidity, this earnings release lacks the surprise or scale required to move the share price materially. It is an incremental update that confirms ongoing survival-mode operations.
TGIF · Price
Company Overview
  • 1933 Industries is a Nevada-focused cannabis operator engaged in cultivation, production, and wholesale distribution.
  • Flagship project: Alternative Medicine Association (AMA) LLC, a 100% owned subsidiary operating a large-scale cultivation and production facility in Nevada.
  • The company's strategy centers on wholesale brand positioning, with AMA consistently ranking in the top 5 for overall cannabis sales and top 3 for concentrates in the Nevada market.
  • Operations are entirely domestic to Nevada, with no disclosed international assets or royalty-bearing properties. The facilities are assumed to be royalty-free, though heavy lease obligations function as a fixed cost burden.
Read the original news release →

More from 1933 Industries Inc.